Cell-Free DNA (cfDNA): Market Size and Share Analysis

Apr 12, 2017
178 Pages - Pub ID: KLI15188961
Share this report
Online Download $3,500
Departmental Site License (one location, up to 10 users) $5,250
Global Site License $7,000
Cell-Free DNA (cfDNA) Markets: Consumables, Systems/Hardware, Services

The use of cell-free DNA (cfDNA) and “liquid biopsies” of other analytes has received a huge amount of attention in recent years, due to its potential to revolutionize the diagnosis and treatment of several conditions. The main areas where cfDNA analysis has turned into a major application include non-invasive prenatal testing (NIPT); oncology, circulating tumor DNA (ctDNA); and transplantation, donor-derived cell-free DNA (ddcfDNA).

Cell-Free DNA (cfDNA) Markets focuses on the market for cfDNA analysis instruments, consumables, kits, and related software, which includes the sample preparation products and equipment as well as the next generation sequencing (NGS) and digital polymerase chain reaction (dPCR) systems used for detection. The report provides complete market information, including current market estimates and forecasts to 2021, as well as:
  • Growth Rate for cfDNA Market, 2016-2021
  • cfDNA Clinical Diagnostics Market, 2016-2021
  • cfDNA Clinical Diagnostics Market Growth Rate, 2016-2021
  • cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
  • cfDNA Instruments and Consumables Revenues by Product Type, 2016 (Consumables, Systems/hardware, Services)
  • Market Share by Company of the cfDNA Analysis Instruments, Consumables, and Software Market, 2016
The report provides information on cfDNA analysis products, commenting not only on reagents, consumables, kits, systems, software, and services, but also on oncology cfDNA products, cfDNA transplantation diagnostics, and other products employing cfDNA.

In the cfDNA market there are many technical challenges to overcome, along with a range of competitive, regulatory, and IP issues. Cancer is a dynamic and defiant disease. While NIPT is a proven application, oncology will require much more difficult work and is more uncertain. The variety of potential issues and threats in the market are covered in the challenges and strategic recommendations chapter of the report. The competitive situation, deals, and litigation are covered in respective chapters as well.

Cell-Free DNA (cfDNA) Markets covers not just the dynamics of the market but also its competitive landscape. For example, several companies are licensing their technologies or offering services. The report profiles those companies competing in the cfDNA instruments and consumables market, including:
  • Agilent Technologies
  • Bio-Rad
  • F. Hoffmann-La Roche AG
  • Fluidigm
  • Illumina
  • Qiagen
  • RainDance Technologies
  • Thermo Fisher Scientific
The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.

NIPT, Oncology Leading Market Forward

Sensitivity Benefits of dPCR, qPCR, NGS

Challenges, Biological and Technologies Limitations

Scope and Methodology


NIPT Companies, Others Shifting Strategies to Cancer

Expanding Clinical Adoption Sustains High Growth

Government Initiatives -- Cancer Moonshot, Blood Profiling Atlas

Mergers, Acquisitions, Equity Investments Increasing

China Becoming Major Player in Market

Personalized, Proactive Medicine Gaining Momentum

Expected Sequencer Platforms Stalled or Cancelled

Significant Efforts in Automation, Miniaturization

Regulatory Situation Unclear But Evolving Somewhat


cfDNA Reagents, Consumables, and Kits

cfDNA Systems and Software

cfDNA NIPT Products and Services

cfDNA in Oncology, Transplantation and Other Diseases

cfDNA Other Products

Recent Product/ Service Introductions


Revenues Forecast

Market Size and Forecast

cfDNA Clinical Diagnostics Market

cfDNA Market by Region

Revenues by Product Type

Illumina Sequencing Revenues as Indicator

Agilent Technologies

F. Hoffmann-La Roche AG




RainDance Technologies

Thermo Fisher Scientific

Chapter 6: Challenges and Strategic Recommendations


Strategic Recommendations

List of Exhibits

Chapter 3: cfDNA Analysis Products
Table 3-1: cfDNA Reagents, Consumables, and Kits

Table 3-2: cfDNA Systems and Software

Table 3-3: cfDNA NIPT Products and Services

Table 3-4: Oncology cfDNA Products

Table 3-5: cfDNA Transplantation Diagnostics

Table 3-6: cfDNA Other Products

Chapter 4: Market Analysis

Figure 4-1: Cost of Sequencing a Genome

Table 4-1: Market for cfDNA

Figure 4-2: cfDNA Market, 2015-2021

Table 4-2: Growth Rate for cfDNA Market, 2015-2021

Figure 4-3: Growth Rate in cfDNA Market, 2016-2020

Table 4-3: cfDNA Clinical Diagnostics Market, 2015-2021

Table 4-4: cfDNA Clinical Diagnostics Market Growth Rate, 2015-2021

Table 4-5: cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)

Figure 4-4: cfDNA Market by Region, 2015 (%) (N. America, Europe, Asia-Pacific & ROW)

Table 4-6: cfDNA Instruments and Consumables Revenues by Product Type,2015 (Consumables, Systems/hardware, Services)

Figure 4-5: Breakout of cfDNA Market by Type, 2015 (%) (Consumables,Systems/hardware, Services)

Table 4-7: Illumina Quarterly Sequencing Revenues (2012-2016)

Figure 4-6: Illumina Quarterly Consumables Revenues (2012-2016)

Table 4-8: Illumina Annual Consumables Revenues (2012-2015)

Table 4-9: Illumina Consumables Growth Rates (2013-2015)

Chapter 7: cfDNA Analysis Market Deals

Table 7-1: cfDNA Analysis Market Deals

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.